Buyer profile

Merck Sharp & Dohme LLC

Every published deal in the Exit Mode archive where this buyer appears on the acquiring side.

Country

United States

Deal count

2

Buyer type

Corporate / other

Aggregate disclosed value

Not stated

7 January 2026CompletedHealthcare

Merck Sharp & Dohme LLC to acquire Cidara Therapeutics, Inc.

Merck Sharp & Dohme LLC and Cidara Therapeutics, Inc. entered the Exit Mode archive.

Buyer: Merck Sharp & Dohme LLC
Target: Cidara Therapeutics, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

7 January 2024CompletedHealthcare

Merck Sharp & Dohme LLC to acquire Harpoon Therapeutics, Inc.

Merck Sharp & Dohme LLC and Harpoon Therapeutics, Inc. entered the Exit Mode archive.

Buyer: Merck Sharp & Dohme LLC
Target: Harpoon Therapeutics, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

Keep browsing

Explore the archive from another angle

Explore sectors

Telecommunications Industrials Other Education Aerospace & Defence Financial Services

Browse by deal type

strategic acquisition unknown merger of equals minority stake going private asset sale

Browse by region

United States Europe United Kingdom Other regions

Browse by country

United States Germany United Kingdom Switzerland Spain South Africa

Browse by stage

In review Completed Announced Abandoned

Year archives